Market Overview

UPDATE: Morgan Stanley Cuts PT to $42 on MetLife Following Guidance

Share:
Related MET
MetLife To Buy Logan Circle, Expand Investment Management
6 Stocks To Watch For July 10, 2017

Morgan Stanley reiterated its Overweight rating on MetLife (NYSE: MET) but lowered its price target from $44 to $42.

Morgan Stanley noted, "MetLife's guidance was modestly disappointing, with both EPS and capital expectations running somewhat below our expectations. That said, their guidance is typically conservative (they typically hit at least the high end), and even with lowered numbers, the valuation multiple on stock is very low."

MetLife closed at $33.61 on Wednesday.

Latest Ratings for MET

DateFirmActionFromTo
May 2017FBR CapitalUpgradesMarket PerformOutperform
Mar 2017Bank of AmericaDowngradesBuyNeutral
Jan 2017CitigroupInitiates Coverage OnSell

View More Analyst Ratings for MET
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (MET)

View Comments and Join the Discussion!